Streamlined Research Ethics Review Launched by Clinical Trials Ontario
System provides nimble, efficient review of multi-centre clinical trials, while maintaining highest ethical standards
A new streamlined approach for the ethical review and oversight of multi-center clinical trials in Ontario was launched by Clinical Trials Ontario (CTO), a stakeholder-led organization established by the Government of Ontario in 2012.
The CTO Streamlined Research Ethics Review System allows any single ‘CTO Qualified’ research ethics board in Ontario to provide ethical review and oversight on behalf of multiple research sites involved in a clinical trial. This replaces the current approach to conduct a research ethics review at each institution participating in the same clinical trial.
Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
